HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1894923Generated: October 31, 2026
(S)-1-(3,4-Dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)-N-methylmethanamine → Ivabradine
https://huagongshe.com/reaction/1894923
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | (S)-1-(3,4-Dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)-N-methylmethanamine | HCID 11499437 | — |
| Reactant | 3-(7,8-Dimethoxy-2-oxo-1,2,4,5-tetrahydro-benzo[d]azepin-3-yl)-propionaldehyde | HCID 20144184 | — |
| Product | Ivabradine | HCID 132999 | — |
Reaction Steps
1 mmol of [(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]-N-methylmethanamine and 1 mmol of 3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)propanal are introduced into a clean and dry stainless-steel autoclave under an argon atmosphere. The mixture is degassed by three vacuum/argon cycles and 3 mL of distilled and degassed ethanol are added. The solution is stirred at 85° C. for one hour. The iron complex (5 mol %) is added under argon. The autoclave is then placed under hydrogen pressure (5 bars) and the reaction mixture is stirred at 85° C. for 16 hours and then the autoclave is returned to ambient temperature and decompressed.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08513410B2 |
|---|
| Source dataset | uspto-grants-2013_08 |
|---|
| ORD ID | ord-b3d3321b184e400882c5d3eae47eac2c |
|---|
| Source note | uspto-grants-2013_08 |
|---|